Search

Design Therapeutics Inc

Закрыт

13.87 -8.33

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

14.9

Макс.

15.19

Ключевые показатели

By Trading Economics

Доход

-1.6M

-18M

Прибыль на акцию

-0.29

Сотрудники

54

EBITDA

534K

-17M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+36.6% upside

Дивиденды

By Acuity

Следующий отчет о доходах

5 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

128M

927M

Предыдущая цена открытия

22.2

Предыдущая цена закрытия

13.87

Design Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 июл. 2026 г., 23:51 UTC

Cryptocurrency market mixed as Bitcoin dips and Ethereum rises ahead of key U.S. inflation data releases impacting Federal Reserve policy.

12 июл. 2026 г., 23:51 UTC

Markets brace for key U.S. inflation and retail sales data releases, with potential implications for Federal Reserve policy amid ongoing economic pressures.

12 июл. 2026 г., 23:51 UTC

Cryptocurrency market shows mixed performance ahead of key U.S. inflation data, as Federal Reserve signals focus on AI in monetary policy.

12 июл. 2026 г., 23:51 UTC

Cryptocurrency market shows mixed performance ahead of critical U.S. economic data releases that may impact Federal Reserve monetary policy.

12 июл. 2026 г., 23:51 UTC

Bank of Korea Expected to Maintain Interest Rate at 2.5% Amid Rising Inflation and Economic Uncertainty

12 июл. 2026 г., 23:51 UTC

China's House Price Index YoY Release on July 15 Expected to Show Continued Decline Amidst Ongoing Property Sector Challenges and Global Economic Uncertainty.

12 июл. 2026 г., 23:41 UTC

US Import Prices Expected to Decrease by 0.4% Amid Cautious Market Sentiment and Geopolitical Tensions Ahead of Key Economic Data Releases

12 июл. 2026 г., 23:41 UTC

Housing Starts Data Release on July 17, 2026: Analysts Brace for Weakness Amid High Mortgage Rates and Economic Pressures.

12 июл. 2026 г., 23:41 UTC

US Export Prices Expected to Rise Amid Inflation Concerns and Geopolitical Tensions Ahead of Key Economic Data Releases

12 июл. 2026 г., 23:41 UTC

U.S. Building Permits MoM Prel for June 2026 Set to Release Amid Heightened Focus on Housing Trends and Legislative Changes

12 июл. 2026 г., 23:41 UTC

Upcoming U.S. Housing Starts Data Release on July 17 Expected to Influence Economic Outlook Amid Legislative Changes and Key Macroeconomic Indicators.

12 июл. 2026 г., 23:41 UTC

U.S. Building Permits Data Release on July 17 Expected to Show Annualized Rate of 1.42 Million Amid Cautious Market Sentiment and Key Macroeconomic Indicators Ahead.

12 июл. 2026 г., 23:41 UTC

Macro News
Correlated Moves

The US 30Y Treasury Bond Index is lower as capital shifts to technology sectors, with rising oil prices amid U.S.-Iran tensions impacting safe-haven demand.

12 июл. 2026 г., 23:31 UTC

Australia's NAB Business Confidence Index set for release amid cautious sentiment and global economic uncertainties.

12 июл. 2026 г., 23:21 UTC

Philadelphia Fed Manufacturing Index Release on July 16 Expected to Show Moderate Optimism Amidst Cautious Market Sentiment and Geopolitical Tensions.

12 июл. 2026 г., 23:21 UTC

U.S. Retail Sales Expected to Rise 0.3% in June Amid Cautious Optimism and Key Economic Indicators Ahead of Fed Policy Insights

12 июл. 2026 г., 23:21 UTC

U.S. Retail Sales Ex Autos Expected to Decline 0.1% in June Amid Economic Caution and Geopolitical Tensions

12 июл. 2026 г., 23:11 UTC

Canada's housing starts data set for July 16, 2026, expected to show resilience with a forecast of 260K units amid positive government initiatives.

12 июл. 2026 г., 23:01 UTC

NZD/CHF has moved higher in after-market trading, currently 1.22% above its 20-day moving average. No specific news was identified for the price move.

12 июл. 2026 г., 23:01 UTC

Macro News
Correlated Moves

The U.S. dollar strengthens against major currencies, contributing to a modest after-hours gain in USD/CHF amid rising geopolitical tensions and a higher Dollar Index.

12 июл. 2026 г., 23:01 UTC

Macro News
Correlated Moves

GBP/USD is trading lower after the U.S. dollar strengthened against major currencies amid geopolitical tensions and anticipation of key macroeconomic data releases.

12 июл. 2026 г., 23:01 UTC

Macro News

The U.S. dollar rose today, reaching a two-day high against the euro amid geopolitical tensions with Iran affecting shipping route stability.

12 июл. 2026 г., 23:01 UTC

Market anticipates NY Empire State Manufacturing Index reading of 8.7 amid cautious sentiment ahead of key macroeconomic data releases.

12 июл. 2026 г., 23:01 UTC

Core PPI for June 2026 set to rise by 0.4% MoM, signaling cautious market sentiment ahead of key economic indicators and Federal Reserve insights.

12 июл. 2026 г., 23:01 UTC

Market Braces for July 15 PPI Release Amid Anticipated 0.2% Increase and Heightened Volatility from Geopolitical Tensions.

12 июл. 2026 г., 23:01 UTC

The EUR/HUF is trading higher after-market, reaching a session high earlier. Market focus remains on upcoming U.S. inflation data that may impact Fed policy.

12 июл. 2026 г., 23:01 UTC

Palladium is trading lower today, continuing a decline since Friday's close. Market focus remains on upcoming U.S. economic data releases.

12 июл. 2026 г., 23:01 UTC

Macro News
Correlated Moves

Gold prices are lower amid a stronger U.S. dollar and renewed U.S.-Iran military tensions, impacting market sentiment toward safe-haven assets.

12 июл. 2026 г., 23:01 UTC

EUR/NOK is trading lower in after-market hours, reflecting a decline since Friday's close. The price remains near the midpoint of its one-month range.

12 июл. 2026 г., 23:01 UTC

Macro News

Copper prices are lower as geopolitical tensions rise amid U.S.-Iran confrontations. Reports of Iraq's oil agreements may further impact market dynamics.

Сравнение c конкурентами

Изменение цены

Design Therapeutics Inc Прогноз

Целевая цена

By TipRanks

36.6% рост

Прогноз на 12 месяцев

Средняя 20.75 USD  36.6%

Максимум 22 USD

Минимум 20 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для Design Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

5 ratings

5

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat